Literature DB >> 29892827

Analysis of Thyroid Tumorigenesis in Xenograft Mouse Model.

Xuguang Zhu1, Sheue-Yann Cheng2.   

Abstract

Analysis of thyroid tumorigenesis in xenograft mouse model is important to study human thyroid cancer. Recent studies have made big strides toward understanding the molecular mechanisms by which thyroid hormone nuclear receptors (TR) act to maintain normal cellular functions in growth, differentiation, and development. Despite growing interest, the role of TR in oncogenesis remains to be fully elucidated. Two TR genes give rise to three major TR isoforms: TRα1, TRβ1, and TRβ2. These TR subtypes express in a tissue- and development-dependent manner. Research has been directed at understanding the mechanisms by which TR could mediate aberrant cellular signaling that contributes to oncogenesis, at dissecting possible distinct roles of TR isoforms in oncogenesis, and at the differential susceptibility of target tissues to the oncogenic actions of TR. This chapter gives a brief overview of the current undersatanding of known molecular oncogenic actions of TR. Here, we describe analysis of thyroid tumorigenesis used in interrogating the in vivo oncogenic actions of TR.

Entities:  

Keywords:  Oncogenesis; Thyroid hormone receptor; Thyroid tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 29892827      PMCID: PMC7971365          DOI: 10.1007/978-1-4939-7902-8_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  46 in total

1.  SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.

Authors:  Won Gu Kim; Celine J Guigon; Laura Fozzatti; Jeong Won Park; Changxue Lu; Mark C Willingham; Sheue-yann Cheng
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

2.  The c-erb-A protein is a high-affinity receptor for thyroid hormone.

Authors:  J Sap; A Muñoz; K Damm; Y Goldberg; J Ghysdael; A Leutz; H Beug; B Vennström
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

Review 3.  Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation.

Authors:  T Graf; H Beug
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

4.  Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.

Authors:  Hao Ying; Fumihiko Furuya; Li Zhao; Osamu Araki; Brian L West; John A Hanover; Mark C Willingham; Sheue-Yann Cheng
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

5.  Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity.

Authors:  P M Yen; M Ikeda; E C Wilcox; J H Brubaker; R A Spanjaard; A Sugawara; W W Chin
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

6.  A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia.

Authors:  A I Dayton; J R Selden; G Laws; D J Dorney; J Finan; P Tripputi; B S Emanuel; G Rovera; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.

Authors:  Hideyo Suzuki; Mark C Willingham; Sheue-Yann Cheng
Journal:  Thyroid       Date:  2002-11       Impact factor: 6.568

8.  Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.

Authors:  Fumihiko Furuya; Changxue Lu; Mark C Willingham; Sheue-Yann Cheng
Journal:  Carcinogenesis       Date:  2007-07-28       Impact factor: 4.944

9.  Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.

Authors:  Won Gu Kim; Xuguang Zhu; Dong Wook Kim; Lisa Zhang; Electron Kebebew; Sheue-Yann Cheng
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

10.  Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma.

Authors:  K Sisley; D Curtis; I G Rennie; R C Rees
Journal:  Melanoma Res       Date:  1993-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.